Merrimack Pharma Shares Down 50.7% Since SmarTrend's Sell Call (MACK)

SmarTrend identified a Downtrend for Merrimack Pharma (NASDAQ:MACK) on December 6th, 2017 at $10.55. In approximately 7 months, Merrimack Pharma has returned 50.71% as of today's recent price of...